Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-166
Closed -$1.65K – 1403
2025
Q3
$1.65K Buy
166
+1
+0.6% +$10 ﹤0.01% 1214
2025
Q2
$1.48K Buy
165
+58
+54% +$490 ﹤0.01% 1229
2025
Q1
$935 Buy
107
+1
+0.9% +$10 ﹤0.01% 1277
2024
Q4
$1.32K Hold
106
– – ﹤0.01% 1081
2024
Q3
$1.23K Buy
106
+1
+1% +$12 ﹤0.01% 1158
2024
Q2
$1.12K Buy
105
+1
+1% +$11 ﹤0.01% 1157
2024
Q1
$1.25K Hold
104
– – ﹤0.01% 1170
2023
Q4
$1.12K Sell
104
-5
-5% -$48 ﹤0.01% 513
2023
Q3
$1.07K Sell
109
-23
-17% -$239 ﹤0.01% 526
2023
Q2
$1.31K Buy
132
+2
+2% +$19 ﹤0.01% 556
2023
Q1
$1.25K Sell
130
-23
-15% -$255 ﹤0.01% 631
2022
Q4
$1.7K Buy
153
+1
+0.7% +$10 ﹤0.01% 591
2022
Q3
$1K Buy
152
+2
+1% +$20 ﹤0.01% 689
2022
Q2
$2K Buy
150
+1
+0.7% +$11 ﹤0.01% 587
2022
Q1
$2K Buy
149
+1
+0.7% +$13 ﹤0.01% 563
2021
Q4
$2K Buy
+148
New +$1.98K ﹤0.01% 534

Other funds holding VTRS

Rise Advisors's VTRS Position: Q4 2025 in Review

Rise Advisors sold out of Viatris (VTRS) in Q4 2025, closing a stake of 166 shares — an estimated $1.65K sold.

Rise Advisors first reported a position in VTRS in Q4 2021 and held it in 16 quarters. The position peaked at $2K in Q2 2022. 1,010 funds tracked by Wall St. Rank hold VTRS as of Q4 2025.

  • Rise Advisors reported no remaining Viatris position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 166 Viatris shares in Q4 2025, an estimated $1.65K.
  • Rise Advisors first reported a position in Viatris in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's Viatris position peaked at $2K in Q2 2022.
  • 1,010 funds tracked by Wall St. Rank held Viatris as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.